JP2024516297A5 - - Google Patents
Info
- Publication number
- JP2024516297A5 JP2024516297A5 JP2023567994A JP2023567994A JP2024516297A5 JP 2024516297 A5 JP2024516297 A5 JP 2024516297A5 JP 2023567994 A JP2023567994 A JP 2023567994A JP 2023567994 A JP2023567994 A JP 2023567994A JP 2024516297 A5 JP2024516297 A5 JP 2024516297A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- anhedonia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/307,858 | 2021-05-04 | ||
| US17/307,858 US11266627B1 (en) | 2021-05-04 | 2021-05-04 | Compositions and methods for the treatment of depression |
| US17/670,123 US12161622B2 (en) | 2021-05-04 | 2022-02-11 | Compositions and methods for the treatment of depression |
| US17/670,123 | 2022-02-11 | ||
| US202263313792P | 2022-02-25 | 2022-02-25 | |
| US63/313,792 | 2022-02-25 | ||
| PCT/IB2022/054085 WO2022234457A1 (en) | 2021-05-04 | 2022-05-03 | Compositions and methods for the treatment of depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516297A JP2024516297A (ja) | 2024-04-12 |
| JP2024516297A5 true JP2024516297A5 (https=) | 2025-05-13 |
Family
ID=81654924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567994A Pending JP2024516297A (ja) | 2021-05-04 | 2022-05-03 | うつ病の治療のための組成物及び方法 |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP4333835A1 (https=) |
| JP (1) | JP2024516297A (https=) |
| KR (1) | KR20240004857A (https=) |
| AU (1) | AU2022268720A1 (https=) |
| BR (1) | BR112023023030A2 (https=) |
| CA (1) | CA3219079A1 (https=) |
| CL (1) | CL2023003259A1 (https=) |
| CO (1) | CO2023015571A2 (https=) |
| IL (1) | IL308221A (https=) |
| JO (1) | JOP20230276A1 (https=) |
| MX (1) | MX2023013040A (https=) |
| PE (1) | PE20241784A1 (https=) |
| PH (1) | PH12023552963A1 (https=) |
| TW (1) | TW202313003A (https=) |
| UY (1) | UY39754A (https=) |
| WO (1) | WO2022234457A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12161622B2 (en) | 2021-05-04 | 2024-12-10 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
| CN119156211A (zh) | 2022-03-07 | 2024-12-17 | 杨森制药公司 | 用于治疗重性抑郁障碍的多晶型形式的阿替卡普兰 |
| WO2023170547A1 (en) * | 2022-03-07 | 2023-09-14 | Janssen Pharmaceuticals, Inc. | Pure forms of crystalline aticaprant |
| EP4489730B1 (en) | 2022-03-07 | 2026-01-21 | Janssen Pharmaceuticals, Inc. | Compositions comprising aticaprant |
| WO2024216046A1 (en) * | 2023-04-13 | 2024-10-17 | Neumora Therapeutics, Inc. | Methods of treating anhedonia |
| WO2024216061A1 (en) * | 2023-04-13 | 2024-10-17 | Neumora Therapeutics, Inc. | Methods of treating depression and anhedonia |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009094260A1 (en) | 2008-01-22 | 2009-07-30 | Eli Lilly And Company | Kappa selective opioid receptor antagonist |
-
2022
- 2022-05-03 AU AU2022268720A patent/AU2022268720A1/en active Pending
- 2022-05-03 WO PCT/IB2022/054085 patent/WO2022234457A1/en not_active Ceased
- 2022-05-03 CA CA3219079A patent/CA3219079A1/en active Pending
- 2022-05-03 TW TW111116720A patent/TW202313003A/zh unknown
- 2022-05-03 MX MX2023013040A patent/MX2023013040A/es unknown
- 2022-05-03 PE PE2023003004A patent/PE20241784A1/es unknown
- 2022-05-03 IL IL308221A patent/IL308221A/en unknown
- 2022-05-03 JP JP2023567994A patent/JP2024516297A/ja active Pending
- 2022-05-03 BR BR112023023030A patent/BR112023023030A2/pt unknown
- 2022-05-03 EP EP22723794.8A patent/EP4333835A1/en active Pending
- 2022-05-03 PH PH1/2023/552963A patent/PH12023552963A1/en unknown
- 2022-05-03 KR KR1020237041546A patent/KR20240004857A/ko active Pending
- 2022-05-04 UY UY0001039754A patent/UY39754A/es unknown
-
2023
- 2023-11-02 CL CL2023003259A patent/CL2023003259A1/es unknown
- 2023-11-02 JO JOJO/P/2023/0276A patent/JOP20230276A1/ar unknown
- 2023-11-17 CO CONC2023/0015571A patent/CO2023015571A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024516297A5 (https=) | ||
| US10682354B2 (en) | Compositions and methods | |
| US8304431B2 (en) | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists | |
| TWI330083B (en) | Methods for treating or preventing symptoms of hormonal variations | |
| US20050203130A1 (en) | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists | |
| JP2000508341A (ja) | 片頭痛の治療法及び薬効の強化組成物 | |
| JP2010535801A5 (https=) | ||
| EP0591434A1 (en) | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron | |
| JP2024507638A (ja) | 性機能障害処置のための神経刺激性ステロイドの使用 | |
| JPS59193821A (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| US20040092519A1 (en) | New treatment for hot flashes | |
| JP2011502175A (ja) | 非定型抗精神病薬の使用に関連した体重増加を遅延させるための方法および組成物 | |
| US10576045B2 (en) | Low dosage combinations of fluoxetine and reboxetine for treating obesity | |
| Chen et al. | A review of treatment modalities for comorbid neuropathic pain and depression | |
| EP3180015A1 (en) | Methods of treating depression using nmda modulators | |
| McManis et al. | Nausea and vomiting associated with selective serotonin reuptake inhibitors: incidence, mechanisms and management | |
| US10300068B2 (en) | Method of treating insomnia | |
| JP2005511615A (ja) | 神経伝達物質均衡の化学療法 | |
| Oettmeier et al. | The procainebase-infusion: 20 years of experience of an alternative use with several therapeutical effects | |
| TWI355935B (en) | Combination of a taxane and a cyclin-dependent kin | |
| MX2011001631A (es) | Tratamiento de transtornos de ansiedad. | |
| Howland | Therapeutic armamentarium for treating depression | |
| JP2002524509A (ja) | 新規組成物 | |
| KR20000029647A (ko) | 양극성장애의치료방법 | |
| JPH0840903A (ja) | 抗癌剤により誘発される末梢神経障害を予防するための医薬組成物 |